Plus Therapeutics, Inc. (PSTV)
Nasdaq: PSTV · Surgical & Medical Instruments & Apparatus · Austin, TX · filing with the SEC since 2001
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Report filed | Mar 12, 2026 | Mar 31, 2025 | Mar 5, 2024 | Feb 23, 2023 | Feb 24, 2022 | Feb 22, 2021 | Mar 30, 2020 | Mar 29, 2019 | Mar 9, 2018 | Mar 24, 2017 |
| Revenue | 5,213 | 5,824 | 4,913 | · | · | · | · | 3,671 | 2,689 | 4,656 |
| Cost of revenue | · | · | · | · | · | · | · | 1,148 | 1,318 | 2,715 |
| Gross profit | · | · | · | · | · | · | · | · | 146 | 1,941 |
| Research and development | 8,379 | 10,580 | 9,690 | 9,698 | 5,323 | 2,700 | 5,365 | 5,523r | 11,678 | 16,197 |
| Sales and marketing | · | · | · | · | · | · | 468 | 643r | 3,593 | 3,611 |
| General and administrative | 12,132 | 9,939 | 8,544 | 10,238 | 6,853 | 6,406 | 5,290r | 5,579r | 7,594 | 8,563 |
| Total operating expenses | 20,511 | 20,519 | 18,234 | 19,936 | 12,492 | 9,887 | 10,655 | 11,745r | 24,551 | 28,371 |
| Operating income | -15,298 | -14,695 | -13,321 | -19,712 | -12,492 | -9,584 | -3,657 | -8,762r | -20,683 | -19,706 |
| Interest expense | 548 | 179 | 395 | 711 | 932 | 1,107 | 1,855 | 1,922 | 2,049 | 2,592 |
| Interest and investment income | 116 | 273 | 400 | 147 | 19 | 50 | 55 | 43 | 33 | 19 |
| Other income (expense), net | · | · | · | · | · | · | · | 180 | 13 | 233 |
| Total non-operating income (expense) | -7,088 | 1,717 | 5 | -563 | -907 | 1,343 | 374 | -116r | -2,003 | -2,340 |
| Income before income taxes | -22,386 | -12,978 | · | · | · | · | · | · | · | · |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income from continuing operations | · | · | · | · | · | -8,241 | -3,283 | -8,878 | · | · |
| Income from discontinued operations | · | · | · | · | · | 0 | -7,604 | -3,756 | · | · |
| Net income | -22,386 | -12,978 | -13,316 | -20,275 | -13,399 | -8,241 | -10,887 | -12,634 | -22,686 | -22,046 |
| Net income to common shareholders | · | · | · | · | · | -8,241 | -11,441 | -15,121 | -26,663 | -22,046 |
| Earnings per share, basic | -0.29 | -1.95 | -4.24 | -11.58r | -16.65b | · | · | · | · | · |
| Earnings per share, diluted | -0.29 | -2.34 | -4.24 | -11.58r | -16.65b | · | · | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -16.65b | -27.90b | -124.05b | -1,304.70rb | -123.45rb | -19.20b |
| Weighted average shares, basic | 77,804,612 | 6,640,251 | 3,140,925 | 1,750,350r | 805,946b | · | · | · | · | · |
| Weighted average shares, diluted | 77,804,612 | 7,700,774 | 3,140,925 | 1,750,350r | 805,946b | · | · | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 805,946b | 295,189b | 92,267b | 11,590rb | 215,932rb | 1,152,729b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:Revenues
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpense
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitIncome from continuing operations profit from the businesses it keeps
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestIncome from discontinued operations profit or loss from businesses it sold or closed
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted